View of SOME RISK FACTORS OF CARDIOVASCULAR-METABOLISM AND EVALUATION OF TREATMENT RESULTS WITH EMPAGLIFLOZIN COMBINED METFORMIN IN TYPE 2 DIABETES WITH OVERWEIGHT AND OBESITY

Return to Article Details SOME RISK FACTORS OF CARDIOVASCULAR-METABOLISM AND EVALUATION OF TREATMENT RESULTS WITH EMPAGLIFLOZIN COMBINED METFORMIN IN TYPE 2 DIABETES WITH OVERWEIGHT AND OBESITY Download Download PDF